Boston Scientific Lowers 2026 Profit and Revenue Growth Forecasts
Boston Scientific has lowered its 2026 adjusted profit forecast and trimmed its full-year organic revenue growth outlook. The company reported first-quarter results that beat expectations, but the revised guidance led to pre-market volatility. Analysts are questioning whether the guidance cut reflects deteriorating trends or investor pressure.
Tickers: $ABT $BSX $JNJ $MDT $PEN
Topics: Company Guidance Earnings Report Medical Device Industry Profit Forecast Revenue Growth